4//SEC Filing
GOODMAN JESSE 4
Accession 0001209191-21-043377
CIK 0001652130other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 6:08 PM ET
Size
8.9 KB
Accession
0001209191-21-043377
Insider Transaction Report
Form 4
GOODMAN JESSE
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-23+3,382→ 3,382 totalExercise: $83.59Exp: 2031-06-22→ Common Stock (3,382 underlying) - Award
Common Stock
2021-06-23+2,094→ 2,094 total
Holdings
- 38,000
Stock Option (right to buy)
Exercise: $18.52Exp: 2028-10-28→ Common Stock (38,000 underlying)
Footnotes (4)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]This option was granted on June 23, 2021 with respect to 3,382 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.
- [F3]As was previously reported, this option was granted on October 29, 2018 with respect to 38,000 shares of Common Stock, with 33% vesting on October 29, 2019 and the remaining 67% vesting in eight substantially equal quarterly installments thereafter.
- [F4]The expiration date of the reported grant was mistakenly reported in a Form 4 filed on 10/31/2018 as 10/28/2018.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001756929
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 6:08 PM ET
- Size
- 8.9 KB